Psyence Biomedical Ltd(PBM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

PBM Psyence Biomedical Ltd

Not Yet Opened 12-20 16:00:00 EST

3.18

+0.72

+29.27%

盘后2.30

-0.88-27.67%

19:59 EST

High4.25	Low2.78	Vol24.09M
Open3.94	D1 Closing2.46	Amplitude59.76%
Mkt Cap2.69M	Tradable Cap2.11M	Total Shares845.06K
T/O98.91M	T/O Rate3,635.40%	Tradable Shares662.78K
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"PBM","market":"US","secType":"STK","nameCN":"Psyence Biomedical Ltd","latestPrice":3.18,"timestamp":1734728400000,"preClose":2.46,"halted":0,"volume":24094764,"hourTrading":{"tag":"盘后","latestPrice":2.3,"preClose":3.18,"latestTime":"19:59 EST","volume":487774,"amount":1116500.3624,"timestamp":1734742798945},"delay":0,"floatShares":662781,"shares":845060,"eps":-588.7374,"marketStatus":"Not Yet Opened","change":0.72,"latestTime":"12-20 16:00:00 EST","open":3.94,"high":4.25,"low":2.78,"amount":98906138.943084,"amplitude":0.597561,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-588.7374,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1734944400000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":2.46,"preHourTrading":{"tag":"盘前","latestPrice":3.94,"preClose":2.46,"latestTime":"09:29 EST","volume":2855392,"amount":12527090.12064,"timestamp":1734704999999},"postHourTrading":{"tag":"盘后","latestPrice":2.3,"preClose":3.18,"latestTime":"19:59 EST","volume":487774,"amount":1116500.3624,"timestamp":1734742798945},"volumeRatio":1.579726878924006},"requestUrl":"/m/hq/s/PBM/wiki","defaultTab":"wiki","newsList":[{"id":"2493472212","title":"BRIEF-Psyence Biomedical Files Prospectus Relates To Potential Offer, Sale, From Time To Time 10.9 Million Common Shares By Selling Securityholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2493472212","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493472212?lang=en_us&edition=fundamental","pubTime":"2024-12-21 05:53","pubTimestamp":1734731626,"startTime":"0","endTime":"0","summary":"BRIEF-Psyence Biomedical Files Prospectus Relates To Potential Offer, Sale, From Time To Time 10.9 Million Common Shares By Selling SecurityholdersDec 20 (Reuters) - Psyence Biomedical Ltd PBM.O:PSYEN","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241220:nFWN3NL1HO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBM","BK4139"],"gpt_icon":1},{"id":"2493747477","title":"Psyence Biomedical files to sell 10.9M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2493747477","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493747477?lang=en_us&edition=fundamental","pubTime":"2024-12-21 05:30","pubTimestamp":1734730246,"startTime":"0","endTime":"0","summary":"16:27 EST Psyence Biomedical (PBM) files to sell 10.9M shares of common stock for holders Published first on TheFly – the ultimate source for real-...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/psyence-biomedical-files-to-sell-10-9m-shares-of-common-stock-for-holders?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/psyence-biomedical-files-to-sell-10-9m-shares-of-common-stock-for-holders?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","PBM"],"gpt_icon":0},{"id":"2493471223","title":"Psyence Biomedical Files Prospectus Relates to Potential Offer, Sale, From Time to Time 10.9 Mln Common Shares by Selling Securityholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2493471223","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493471223?lang=en_us&edition=fundamental","pubTime":"2024-12-21 05:20","pubTimestamp":1734729606,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241220:nFWN3NL1HO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PBM"],"gpt_icon":0},{"id":"2492448472","title":"Investors Await Key Inflation Data as US Futures Decline in Friday's Premarket","url":"https://stock-news.laohu8.com/highlight/detail?id=2492448472","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492448472?lang=en_us&edition=fundamental","pubTime":"2024-12-20 21:06","pubTimestamp":1734699963,"startTime":"0","endTime":"0","summary":"US stock futures were trending lower in Friday's premarket session as investors await key inflation data set for release later in the morning.The Dow Jones Industrial Average futures were down 0.62%, ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"0136878ef76de94ac274d4d3726d77de","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NVNI","PBM","BK4023","MYSZ","MTEM","BK4139","HYZN","BK4149","CYN","ISBC","BK4211"],"gpt_icon":1},{"id":"2492418148","title":"US Stocks To Open Lower As Traders Brace For 'Triple Witching' Hour: Analyst Says End Of The Year Recovery 'Would Not Surprise Anyone'","url":"https://stock-news.laohu8.com/highlight/detail?id=2492418148","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492418148?lang=en_us&edition=fundamental","pubTime":"2024-12-20 18:37","pubTimestamp":1734691077,"startTime":"0","endTime":"0","summary":"U.S. futures declined on Friday, ahead of the &#39;Triple Witching&#39; hour, which is expected to see $6.6 trillion options expire, for the quarter.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/24/12/42611748/us-stocks-to-open-lower-as-traders-brace-for-triple-witching-hour-analyst-says-end-of-the-year-recovery-would-not-surprise-anyone","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0128525689.USD","BK4099","LU1571399168.USD","QQQ","SSO","LU0786609619.USD","BK4581","CCL","LU0251142724.SGD","BK4566","VOO","SPXU","TQQQ","UPRO","QID","HUMA","TSYW.SI","OEF","QLD","LU0742534661.SGD","BK4563","USAW.SI","FDX",".IXIC","PBM","NVIW.SI","NKE","USJW.SI","BK4517","NQmain","MNQmain",".SPX","OEX","SQQQ","LU1267930227.SGD","BK4504","SDS","LU1303367103.USD","PSQ","LU2098885051.SGD","SH","BK4593","SPY","LU0052756011.USD","ESmain","IVV","BK4585","WGO","BK4533"],"gpt_icon":1},{"id":"2492848731","title":"Republicans spending package includes no PBM reform, Punchbowl says","url":"https://stock-news.laohu8.com/highlight/detail?id=2492848731","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492848731?lang=en_us&edition=fundamental","pubTime":"2024-12-20 05:40","pubTimestamp":1734644439,"startTime":"0","endTime":"0","summary":"Jake Sherman of Punchbowl News reports that House Republicans are eyeing a package to extend government funding for three months and suspend the de...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/republicans-spending-package-includes-no-pbm-reform-punchbowl-says?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/republicans-spending-package-includes-no-pbm-reform-punchbowl-says?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","PBM"],"gpt_icon":0},{"id":"2492127458","title":"PBM reform looks manageable for CVS Health, says UBS","url":"https://stock-news.laohu8.com/highlight/detail?id=2492127458","media":"TipRanks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492127458?lang=en_us&edition=fundamental","pubTime":"2024-12-19 20:25","pubTimestamp":1734611124,"startTime":"0","endTime":"0","summary":"The House on Tuesday released text of its Furthering Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025 which included the first formal language around pharmacy benefit manager reform, UBS tells investors. Based on conversations with industry expects, the Act, while incremental, does not include any adverse new ideas that would materially harm PBM profits, and the text allows enough room and time for PBMs to maneuver and adjust to limit downside risks, UBS says. The firm made no change to its Neutral rating or $62 price target on CVS Health  shares and says there may be a near-term relief in CVS stock.Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks. Barclays fact-checked Trump comments on pharmacy benefit managers. Trump Vows to “Knock Out the Middleman” to Bring Down Drug Costs. CVS shares slip as Trump says ‘going to knock out the middle m","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/jyW8LnVWcNPxz0nC382F_Q--~B/aD0xOTI7dz0xOTI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/tipranks_452/b2ab5ce41e2f765a8a000168a0a58a9c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/jyW8LnVWcNPxz0nC382F_Q--~B/aD0xOTI7dz0xOTI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/tipranks_452/b2ab5ce41e2f765a8a000168a0a58a9c"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/pbm-reform-looks-manageable-cvs-122524034.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pbm-reform-looks-manageable-cvs-122524034.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4588","IE00BSNM7G36.USD","LU0061475181.USD","LU0006061336.USD","BK4196","LU0211331839.USD","BK4550","LU0162691827.USD","BK4585","LU1571399168.USD","IE00BZ1G4Q59.USD","CVS","IE00BKVL7J92.USD","LU0072461881.USD","LU1059921491.USD","LU0070302665.USD","LU1699723380.USD","LU0320765489.SGD","PBM","BK4581","BK4504","LU0208291251.USD","BK4139"],"gpt_icon":0},{"id":"2492416520","title":"S&P 500 Gains and Losses Today: Index Drops as Fed Cuts Rates but Signals Caution","url":"https://stock-news.laohu8.com/highlight/detail?id=2492416520","media":"Investopedia","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492416520?lang=en_us&edition=fundamental","pubTime":"2024-12-19 05:57","pubTimestamp":1734559071,"startTime":"0","endTime":"0","summary":"The S&P 500 plunged 3% on Wednesday, Dec. 18, 2024, as the Fed cut interest rates but struck a more cautious tone about future policy moves.Shares of cloud-based human resources services provider Paycom plummeted, despite a pair of recent price target boosts.Jabil shares surged after the circuit board maker posted better-than-expected quarterly results and raised its full-year guidance.After trading higher for much of the day, the S&P 500 changed course following the rate-cut announcement and as Fed Chair Jerome Powell addressed the press, ending with a daily loss of 3%. The Dow finished the session down 2.6%, extending its streak of down days to double digits for the first time in four decades. The Nasdaq dropped 3.6% as concerns about the interest-rate outlook weighed on the tech sector.Following a series of gains that lifted the semiconductor maker above the $1 trillion market capitalization milestone, Broadcom  shares declined for a second straight day, losing 6.9%. Although Broadc","market":"nz","thumbnail":"https://www.investopedia.com/thmb/niYkVGKfAnVR5YPc_keNYpTHsFY=/6960x4640/filters:no_upscale():max_bytes(150000):strip_icc()/GettyImages-2190484741-c29990ca004a4fbfb76ef2e78de3a42a.jpg","type":0,"news_type":0,"thumbnails":["https://www.investopedia.com/thmb/niYkVGKfAnVR5YPc_keNYpTHsFY=/6960x4640/filters:no_upscale():max_bytes(150000):strip_icc()/GettyImages-2190484741-c29990ca004a4fbfb76ef2e78de3a42a.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.investopedia.com/sandp-500-gains-losses-today-index-drops-fed-cuts-rates-signals-caution-tesla-broadcom-8763705","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"investopedia_highlight","symbols":["AVGO","IE0002141913.USD","US30Y.BOND","ESmain","LU2237957902.USD","CVS","LU1301847155.USD","US12M.BOND","SPY","TSYW.SI","LU2347655156.SGD","US7Y.BOND","VOO","US6M.BOND","IE00B3PB1722.GBP","BXP","MACW.SI","UNH","CNC","IE00BVYPNV92.GBP","JBL","PBM","CI","LU0130102774.USD","REIT.AU","US10Y.BOND","SH","TSLA","IE0003U64NQ7.SGD","US3Y.BOND","SPXU","SSO",".SPX","SDS","US2Y.BOND","IE00BN8TJ469.HKD","CVS.AU","IE00BFSS7M15.SGD","IVV","PAYC","IE00BBT3K403.USD","LU2322448957.HKD","OEX","LU0158827781.USD","OEF","US5Y.BOND","UPRO","REIT","IE00BMPRXQ63.HKD"],"gpt_icon":1},{"id":"2492911588","title":"S&P 500 Gains and Losses Today: Health Care Stocks Fall as Trump Eyes 'Middlemen'","url":"https://stock-news.laohu8.com/highlight/detail?id=2492911588","media":"Investopedia","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492911588?lang=en_us&edition=fundamental","pubTime":"2024-12-18 06:10","pubTimestamp":1734473451,"startTime":"0","endTime":"0","summary":"Major U.S. equities indexes faltered as the Federal Reserve kicked off its final two-day policy meeting of 2024.While the central bank is widely expected to announce a third consecutive interest rate cut on Wednesday afternoon, investors are likely preparing to scrutinize the language in the accompanying statement and the subsequent press conference with Fed Chair Jerome Powell for suggestions about what's in store for next year.The S&P 500 slipped 0.4%, while the Nasdaq lost 0.3%. The Dow finished 0.6% lower, extending its losing streak to nine straight negative trading sessions.Fox Corp.  shares added 4.3% following reports that FOX News posted a record of more than 400 million views on YouTube during November, topping all other news platforms. FOX News also holds an advantage over its competitors regarding cable TV ratings and social media engagement. Fox Corp. Class B  shares were up 4.1%.","market":"us","thumbnail":"https://www.investopedia.com/thmb/OFOTbkfdq9fkXjv5CtmH-3ohbbY=/3000x1869/filters:no_upscale():max_bytes(150000):strip_icc()/INV_HumanaBuilding_GettyImages-148448576-4f80a4a42be344558c9f3f7df7094384.jpg","type":0,"news_type":0,"thumbnails":["https://www.investopedia.com/thmb/OFOTbkfdq9fkXjv5CtmH-3ohbbY=/3000x1869/filters:no_upscale():max_bytes(150000):strip_icc()/INV_HumanaBuilding_GettyImages-148448576-4f80a4a42be344558c9f3f7df7094384.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.investopedia.com/s-and-p-500-gains-and-losses-today-health-care-stocks-fall-as-trump-eyes-middlemen-8763010","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"investopedia_highlight","symbols":["AVGO","IE0009G5SDU7.USD","SDS","LU0661504455.SGD","BK4551","VOO","SPY","MACW.SI","FOXA","HUM.AU","US12M.BOND","IVV",".SPX","SH","UPRO","US2Y.BOND","IE00B4JS1V06.HKD","BK4579","TSYW.SI","PFE","LU2322448791.USD","LU1316542783.SGD","LU2286300806.USD","IE000M9KFDE8.USD","PFE.AU","BK4554","US5Y.BOND","BK4196","US7Y.BOND","AMTM","CVS.AU","SSO","HUM","SPXU","CVS","OEX","LU0198837287.USD","ESmain","LU2237438978.USD","OEF","TSLA","US3Y.BOND","US6M.BOND","US10Y.BOND","PBM","US30Y.BOND","BK4559","FOX"],"gpt_icon":1},{"id":"2492508999","title":"Psyence Biomedical highlights progress on Phase IIb clinical trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2492508999","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492508999?lang=en_us&edition=fundamental","pubTime":"2024-12-17 21:46","pubTimestamp":1734443195,"startTime":"0","endTime":"0","summary":"Psyence Biomedical (PBM) highlighted recent progress that has been made with its active Phase IIb clinical trial of nature derived psilocybin, in c...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/psyence-biomedical-highlights-progress-on-phase-iib-clinical-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/psyence-biomedical-highlights-progress-on-phase-iib-clinical-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PBM","BK4139"],"gpt_icon":0},{"id":"2492295793","title":"Psyence Biomed Highlights Recent Progress on Active Phase Iib Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2492295793","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492295793?lang=en_us&edition=fundamental","pubTime":"2024-12-17 21:37","pubTimestamp":1734442642,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241217:nTUABNJWN3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PBM","BK4139"],"gpt_icon":0},{"id":"2492889621","title":"S&P 500 Gains and Losses Today: Tesla Stock Boosted by AI, Self-Driving Optimism","url":"https://stock-news.laohu8.com/highlight/detail?id=2492889621","media":"Investopedia","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492889621?lang=en_us&edition=fundamental","pubTime":"2024-12-17 05:47","pubTimestamp":1734385660,"startTime":"0","endTime":"0","summary":"Major U.S. equities indexes were mixed to launch the trading week ahead of Wednesday's key Federal Reserve interest-rate decision.While traders widely expect the central bank to announce another reduction in borrowing costs, comments from Fed Chair Jerome Powell and a slew of other economic data will likely be in focus this week as investors aim to gauge the trajectory of the economy and future policy moves.The S&P 500 advanced 0.4%, while strength in the communication and technology sectors helped drive a gain of 1.2% and a record closing high for the Nasdaq. The Dow slipped 0.3%.Shares of companies that operate pharmacy benefit management  businesses moved lower after President-elect Donald Trump suggested that eliminating the so-called \"middle man\" could be one way to reduce the cost of prescription drugs. Lawmakers introduced a bipartisan","market":"hk","thumbnail":"https://www.investopedia.com/thmb/2xS2g9nRi9S4gLhcphnj-pVpIOg=/5521x3697/filters:no_upscale():max_bytes(150000):strip_icc()/GettyImages-1466481927-22c36921cd7e4c3f8767f389463f807c.jpg","type":0,"news_type":0,"thumbnails":["https://www.investopedia.com/thmb/2xS2g9nRi9S4gLhcphnj-pVpIOg=/5521x3697/filters:no_upscale():max_bytes(150000):strip_icc()/GettyImages-1466481927-22c36921cd7e4c3f8767f389463f807c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.investopedia.com/s-and-p-500-gains-and-losses-today-tesla-stock-boosted-by-ai-self-driving-optimism-8762339","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"investopedia_highlight","symbols":[".SPX","2NVD.UK","SH","NVDU","CVS.AU","NQmain","US5Y.BOND","US3Y.BOND","SDS","SNVD.UK","FSD","MPC","US10Y.BOND","TSLL","EVR.AU","OEF","NVDS.UK","NVDS","US12M.BOND","EVR","NVIW.SI","OEX","NVDD","SMCI","NVDY","TSLA","US30Y.BOND","NVDX","US6M.BOND","NVDA","TSYW.SI","US2Y.BOND","VOO","3NVD.UK","PBM","MU","CVS","SPXU","SPY","SSO","PSX","US7Y.BOND","AVGO","IVV","NVD","NVD2.UK","UPRO","ESmain","NVD3.UK"],"gpt_icon":1},{"id":"2491135536","title":"CVS Health Hits 11-Year Low; PBM Legislation Could Slash Earnings By 50%, Says Analyst","url":"https://stock-news.laohu8.com/highlight/detail?id=2491135536","media":"Blockhead","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491135536?lang=en_us&edition=fundamental","pubTime":"2024-12-13 03:06","pubTimestamp":1734030399,"startTime":"0","endTime":"0","summary":"New legislation targeting pharmacy benefit managers (PBMs) could cut CVS Health earnings in half. CVS stock fell, along with UnitedHealth and Cigna.","market":"hk","thumbnail":"https://www.investors.com/wp-content/uploads/2017/11/stock-CVS-02-company-150x150.jpg","type":0,"news_type":0,"thumbnails":["https://www.investors.com/wp-content/uploads/2017/11/stock-CVS-02-company-150x150.jpg"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.investors.com/news/cvs-stock-warren-pbm-legislation-unitedhealth-cigna/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"investor_business_daily_highlight","symbols":["CVS","PBM"],"gpt_icon":1},{"id":"2490817525","title":"S&P 500 Gains and Losses Today: Broadcom Soars on Reports of Apple AI Chip Tie-Up","url":"https://stock-news.laohu8.com/highlight/detail?id=2490817525","media":"Investopedia","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490817525?lang=en_us&edition=fundamental","pubTime":"2024-12-12 06:38","pubTimestamp":1733956696,"startTime":"0","endTime":"0","summary":"Major U.S. equities indexes were mixed Wednesday following the release of the latest Consumer Price Index  report.Although annualized price increases in November ticked higher from October levels, the inflation data largely aligned with forecasts, reinforcing expectations that the Federal Reserve will cut interest rates at next week's policy meeting.The S&P 500 added 0.8% in the mid-week trading session, while strength in the tech sector helped drive the Nasdaq up 1.8% to close above the 20,000-point threshold for the first time ever. The Dow ended the day 0.2% lower.Shares of semiconductor and software provider Broadcom  surged 6.6%, in the strongest performance of any S&P 500 stock on Wednesday. The gains followed reports of a collaboration with tech giant Apple  to develop an artificial intelligence  chip code-named Baltra.Health care companies with pharmacy benefit management  operations came under pressure as members of Congress introduced a bipartisan bill that would require heal","market":"sg","thumbnail":"https://www.investopedia.com/thmb/8muNZNHFefGKf7_Lg2XSz9HFAkU=/5327x3398/filters:no_upscale():max_bytes(150000):strip_icc()/GettyImages-13215401221-adb4ae14a88d4680963ff74bee893d16.jpg","type":0,"news_type":0,"thumbnails":["https://www.investopedia.com/thmb/8muNZNHFefGKf7_Lg2XSz9HFAkU=/5327x3398/filters:no_upscale():max_bytes(150000):strip_icc()/GettyImages-13215401221-adb4ae14a88d4680963ff74bee893d16.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.investopedia.com/s-and-p-500-gains-and-losses-today-broadcom-soars-on-reports-of-apple-ai-chip-tie-up-8760033","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"investopedia_highlight","symbols":["GEV.AU","IVV","WBA.AU","LU0545039389.USD","SSO","SPY","IE00B42XCP33.USD","CPI","SPXU","IE0034235188.USD","TSYW.SI","LU0354030511.USD","AAPL","SG9999015952.SGD","CVS.AU","SH","AVGOP","LU2362541513.USD","SG9999014575.USD","AVGO","LU2456880835.USD","LU0823434583.USD","SDS","PBM","BK4213","ESmain","IE0003U64NQ7.SGD","OEX","EQT","UNH","CI","TSLA","LU1582986433.USD","VOO","GM","OEF","WBA","UPRO","LU0321505868.SGD","LU0823434740.USD",".SPX","BK4527","EQT.AU","TPL","LU1153585028.USD","UBER","CVS","GEV"],"gpt_icon":1},{"id":"2490892972","title":"New PBM Legislation Sparks Healthcare Selloff on Wall Street -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2490892972","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490892972?lang=en_us&edition=fundamental","pubTime":"2024-12-12 03:58","pubTimestamp":1733947080,"startTime":"0","endTime":"0","summary":"A new proposal in Congress is adding pressure to the embattled industry of pharmacy-benefit managers, or PBMs, middlemen companies with significant influence in the drug supply chain.Bipartisan legislation introduced Wednesday would prohibit ownership of pharmacies and PBMs under the same roof, and would require companies that currently own both types of businesses to divest the pharmacies within three years.The three largest PBMs are integrated inside UnitedHealth Group, CVS Health, and Cigna Group. Shares of all three companies were down sharply on Wednesday, with declines around 5% for each stock. The broader healthcare sector was falling, as well, even as the rest of the market rallied.Independent pharmacies, however, have argued their reimbursement is at the mercy of competitors, since CVS, UnitedHealth, and Cigna also operate pharmacies.The company added: \"Any policies that would limit our ability to negotiate with drugmakers and pharmacies would ultimately increase the cost of m","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"532a5357d1acb59fd2616af143280ac5","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU0162691827.USD","CI","LU0211331839.USD","LU0070302665.USD","IE00BZ1G4Q59.USD","LU0208291251.USD","LU0289739699.SGD","IE00BKVL7J92.USD","PBM","BK4196","IE0002270589.USD","HCSG","BK4550","LU0058720904.USD","LU1571399168.USD","UNH","IE00B19Z3B42.SGD","LU0868494617.USD","LU0061475181.USD","BK4588","IE00BSNM7G36.USD","CVS","BK4504","BK4137","LU0320765489.SGD","LU1059921491.USD","LU0006061336.USD","LU1699723380.USD","BK4139","LU1261432733.SGD","IE00B19Z3581.USD","BK4581","LU0072461881.USD"],"gpt_icon":1},{"id":"2490891792","title":"CVS Might Just Be the Last Drugstore Stock. Should It Be Broken Up? -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2490891792","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490891792?lang=en_us&edition=fundamental","pubTime":"2024-12-12 03:14","pubTimestamp":1733944440,"startTime":"0","endTime":"0","summary":"CVS could wind up as the only pharmacy stock in the U.S. if Walgreens goes private. But the drugstore chain, worth about $66 billion, could also become much smaller in the not-so-distant future.The company's board has been considering a breakup for a few months now. It's also possible the government could force its hand.A bipartisan group of lawmakers plans to call for healthcare conglomerates like CVS to sell their pharmacy benefit manager  businesses, which negotiate price rebates with pharmaceutical companies and often run their own mail-order pharmacies.CVS owns the giant PBM Caremark. Insurers UnitedHealth and Cigna own Caremark rivals Optum and Express Scripts, respectively.Concerns about high drug prices and the possibility for more regulation in Washington have weighed on shares of CVS, Walgreens, and insurers such as UnitedHealth, Humana, Cigna, and Anthem owner Elevance Health. CVS has plunged 34% in 2024. It was down 5% alone on Wednesday.In mid-October, shortly after the CV","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","LU0061475181.USD","LU0170899867.USD","IE00B19Z3B42.SGD","IE00BSNM7G36.USD","LU0557290698.USD","SG9999001077.SGD","IE00BKVL7J92.USD","LU0314106906.USD","LU1093756325.SGD","LU2362541513.USD","LU1983299246.USD","LU2592432038.USD","LU0320765489.SGD","LU0211331839.USD","ELV","SG9999003800.SGD","BK4504","LU0006061336.USD","LU0072461881.USD","BK4550","LU1699723380.USD","BK4196","LU1506573853.SGD","LU1720051017.SGD","LU0882574055.USD","CI","LU1057294990.SGD","LU0321505868.SGD","LU0345770993.USD","CVS","LU0348723411.USD","LU0238689110.USD","LU0106261372.USD","LU0061474960.USD","PBM","LU1023059063.AUD","LU2505996681.GBP","LU2362541273.HKD","BK4566","LU2237957902.USD","WBA","LU0878866978.SGD","LU0256863811.USD","LU0068578508.USD","LU2357305700.SGD","HUM","BK4154","LU2237957811.SGD","LU1670628061.USD"],"gpt_icon":0},{"id":"2490885400","title":"Psyence Biomedical executes binding agreements with Optimi Health","url":"https://stock-news.laohu8.com/highlight/detail?id=2490885400","media":"TipRanks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490885400?lang=en_us&edition=fundamental","pubTime":"2024-12-11 20:35","pubTimestamp":1733920536,"startTime":"0","endTime":"0","summary":"Psyence Biomedical  announced that it has progressed beyond the previously-announced non-binding Letter of Intent, LOI, and executed binding agreements with Optimi Health Corp. Under the terms of the agreements, Optimi becomes the exclusive supplier of GMP-certified, nature-derived  psilocybin extract for Psyence’s global drug development and commercialization initiatives for FDA-approved uses in the Palliative Care context. Optimi will provide comprehensive Chemistry, Manufacturing, and Control support for regulatory submissions related to Psyence’s clinical trials in Palliative Care and any future Investigational New Drug applications. Psyence will obtain exclusive rights to Optimi’s drug candidate for treatment use in the Palliative Care context.Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks. Psyence Biomedical Boosts Equity to Meet Nasdaq Rules. Psyence Biomed Strength","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/XeRvyTOtez7ZtvQGLwHolQ--~B/aD0xOTI7dz0xOTI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/tipranks_452/7a4d5c5979e9a116d16fdb63289bd4e9","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/XeRvyTOtez7ZtvQGLwHolQ--~B/aD0xOTI7dz0xOTI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/tipranks_452/7a4d5c5979e9a116d16fdb63289bd4e9"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/psyence-biomedical-executes-binding-agreements-123536328.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/psyence-biomedical-executes-binding-agreements-123536328.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PBM","BK4139","PBMWW"],"gpt_icon":0},{"id":"2490284170","title":"Why Walgreens Boots Alliance Soared Today","url":"https://stock-news.laohu8.com/highlight/detail?id=2490284170","media":"Motley Fool","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490284170?lang=en_us&edition=fundamental","pubTime":"2024-12-11 03:04","pubTimestamp":1733857440,"startTime":"0","endTime":"0","summary":"Rumors are that a major private equity firm is circling Walgreens.The stock is down over 60% over the past year and even more from all-time highs.The company has struggled to turn itself around under a new CEO.Shares of Walgreens Boots Alliance  soared 20% on Tuesday, as of 2:35 p.m. ET.The beaten-down retail pharmacy rallied on rumors it might get bought out by a private equity firm. Usually, buyouts happen at a premium to the market stock price, and with shares down 63% on the year and 90% from their highs, there was ample room for a premium over yesterday's closing stock price. Private equity to the rescue?","market":"us","thumbnail":"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F800586%2Fgettyimages-1419247648-1.jpg&op=resize&w=165&h=104","type":0,"news_type":0,"thumbnails":["https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F800586%2Fgettyimages-1419247648-1.jpg&op=resize&w=165&h=104"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.fool.com/investing/2024/12/10/why-walgreens-boots-alliance-soared-today/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["BK4588","WBA","LU0321505439.SGD","PBM","BK4128","BK4585","LU0321505868.SGD","BK4139"],"gpt_icon":0},{"id":"2490977130","title":"BRIEF-Psyence Biomed Executes Agreements With Optimi Health","url":"https://stock-news.laohu8.com/highlight/detail?id=2490977130","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490977130?lang=en_us&edition=fundamental","pubTime":"2024-12-10 20:52","pubTimestamp":1733835165,"startTime":"0","endTime":"0","summary":"BRIEF-Psyence Biomed Executes Agreements With Optimi HealthDec 10 (Reuters) - Psyence Biomedical PBM.O:PSYENCE BIOMED EXECUTES BINDING AGREEMENTS WITH OPTIMI HEALTH CORP.PSYENCE BIOMEDICAL LTD - OPTIM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241210:nTUA5QGR8W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBM","BK4139"],"gpt_icon":0},{"id":"2490921200","title":"Psyence Biomedical Ltd - Optimi to Provide Cmc Support for Psyence's Clinical Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2490921200","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490921200?lang=en_us&edition=fundamental","pubTime":"2024-12-10 20:30","pubTimestamp":1733833800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241210:nTUA5QGR8W:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PBM","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.pacificbooker.bc.ca","stockEarnings":[{"period":"1week","weight":0.7189},{"period":"1month","weight":-0.152},{"period":"3month","weight":-0.6464},{"period":"6month","weight":-0.8913},{"period":"1year","weight":-0.9956},{"period":"ytd","weight":-0.9954}],"compareEarnings":[{"period":"1week","weight":-0.0216},{"period":"1month","weight":0.0011},{"period":"3month","weight":0.0403},{"period":"6month","weight":0.0857},{"period":"1year","weight":0.2506},{"period":"ytd","weight":0.2437}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Newcourt Acquisition Corp. is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on February 25, 2021 and is headquartered in Oakland, CA.","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.261315},{"month":2,"riseRate":0.666667,"avgChangeRate":-0.229033},{"month":3,"riseRate":1,"avgChangeRate":0.362272},{"month":4,"riseRate":0.666667,"avgChangeRate":-0.067007},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.053855},{"month":6,"riseRate":0.666667,"avgChangeRate":-0.193429},{"month":7,"riseRate":1,"avgChangeRate":0.326596},{"month":8,"riseRate":0.666667,"avgChangeRate":-0.094421},{"month":9,"riseRate":0.666667,"avgChangeRate":-0.251038},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.101551},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.109939},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.084496}],"exchange":"NASDAQ","name":"Psyence Biomedical Ltd","nameEN":"Psyence Biomedical Ltd"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Psyence Biomedical Ltd(PBM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Psyence Biomedical Ltd(PBM) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Psyence Biomedical Ltd,PBM,Psyence Biomedical Ltd股票,Psyence Biomedical Ltd股票老虎,Psyence Biomedical Ltd股票老虎国际,Psyence Biomedical Ltd行情,Psyence Biomedical Ltd股票行情,Psyence Biomedical Ltd股价,Psyence Biomedical Ltd股市,Psyence Biomedical Ltd股票价格,Psyence Biomedical Ltd股票交易,Psyence Biomedical Ltd股票购买,Psyence Biomedical Ltd股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Psyence Biomedical Ltd(PBM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Psyence Biomedical Ltd(PBM) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction